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Mendelian randomization analyses are often performed using summarized data. The causal estimate from
a one-sample analysis (in which data are taken from a single data source) with weak instrumental variables
is biased in the direction of the observational association between the risk factor and outcome, whereas
the estimate from a two-sample analysis (in which data on the risk factor and outcome are taken from
non-overlapping datasets) is less biased and any bias is in the direction of the null. When using genetic
consortia that have partially overlapping sets of participants, the direction and extent of bias are uncertain.
In this paper, we perform simulation studies to investigate the magnitude of bias and Type 1 error rate
inﬂation arising from sample overlap. We consider both a continuous outcome and a case-control setting
with a binary outcome. For a continuous outcome, bias due to sample overlap is a linear function of the
proportion of overlap between the samples. So, in the case of a null causal eﬀect, if the relative bias of
the one-sample instrumental variable estimate is 10% (corresponding to an F parameter of 10), then the
relative bias with 50% sample overlap is 5%, and with 30% sample overlap is 3%. In a case-control setting,
if risk factor measurements are only included for the control participants, unbiased estimates are obtained
even in a one-sample setting. However, if risk factor data on both control and case participants are used,
then bias is similar with a binary outcome as with a continuous outcome. Consortia releasing publicly
available data on the associations of genetic variants with continuous risk factors should provide estimates
that exclude case participants from case-control samples.
K E YWORD S
aggregated data, instrumental variables, Mendelian randomization, summarized data, weak instrument
bias
1 INTRODUCTION
Mendelian randomization is the use of genetic variants as
instrumental variables to assess and estimate the causal
eﬀect of a risk factor on an outcome from observational
data (Davey Smith & Ebrahim, 2003; Burgess & Thompson,
2015). A recent methodological development in Mendelian
randomization is the use of summarized data on associa-
tions of genetic variants with the risk factor and with the
outcome to obtain causal eﬀect estimates (Johnson, 2013;
Burgess, Butterworth, & Thompson, 2013). These summa-
rized data comprise the associations of the individual genetic
variants with the risk factor and with the outcome taken
from univariable regression analyses (beta-coeﬃcients and
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standard errors from linear or logistic regression as appro-
priate). Suitable summarized data for such analyses have
been made publicly available for hundreds of thousands of
genetic variants by some large consortia (Burgess et al.,
2015a). Examples include associations of genetic variants
with lipid fractions from the Global Lipids Genetics Con-
sortium (The Global Lipids Genetics Consortium, 2013) and
with type 2 diabetes from the DIAGRAM consortium (Morris
et al., 2012). Mendelian randomization analyses using sum-
marized data have suggested causal eﬀects of adiponectin
on type 2 diabetes risk (Dastani et al., 2012), insulin levels
on endometrial cancer risk (Nead et al., 2015), and telom-
ere length on risk of lung adenocarcinoma (Zhang et al.,
2015).
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The validity of a Mendelian randomization investigation
depends on the instrumental variable (IV) assumptions being
satisﬁed for all genetic variants (Lawlor, Harbord, Sterne,
Timpson, & Davey Smith, 2008). In particular, any genetic
variant used as an IV is assumed to be:
1. Associated with the risk factor;
2. Independent of confounders of the risk factor–outcome
association; and
3. Independent of the outcome conditional on the risk fac-
tor and confounders of the risk factor–outcome association
(Greenland, 2000; Sussman, Wood, & Hayward, 2010).
In this paper, we assume that the IV assumptions are sat-
isﬁed for all genetic variants in the analysis. Variants can be
weak (i.e., they do not explain much variation in the risk fac-
tor), but they are all assumed to be valid IVs.
Although estimates from IV analysis in a one-sample set-
ting (that is, genetic variants, risk factor and outcome are all
measured in the same participants) are asymptotically unbi-
ased, they can have substantial bias in ﬁnite samples (Stock,
Wright, & Yogo, 2002; Burgess & Thompson, 2011). This
bias (known as weak instrument bias) acts in the direction
of the confounded observational association between the risk
factor and outcome (Nelson & Startz, 1990; Bound, Jaeger,
& Baker, 1995). Its magnitude depends on the strength of
association between the IV(s) and the risk factor (Staiger
& Stock, 1997). Weak instrument bias also leads to inﬂated
Type 1 error rates (over-rejection of the null) (Stock & Yogo,
2002). One way of combatting weak instrument bias in prac-
tice is a two-sample analysis strategy, in which the asso-
ciations of IVs with the risk factor and with the outcome
are obtained from two non-overlapping datasets (Angrist
& Krueger, 1992; Inoue & Solon, 2010). In a two-sample
Mendelian randomization analysis, any bias due to weak
instruments is in the direction of the null (Pierce & Burgess,
2013). Bias in the direction of the null is less serious than
bias in the direction of the observational association, as it
is conservative, and so will not lead to inﬂated Type 1 error
rates and false-positive ﬁndings. This bias may lead to lower
power to detect a causal eﬀect and increased probability of
a Type 2 error, although the standard errors typically also
attenuate, mitigating this somewhat (Burgess, Dudbridge, &
Thompson, 2016b).
The use of summarized data in Mendelian randomization
is motivated by the increasing availability of suitable data
in large sample sizes. A fortuitous side-eﬀect is that genetic
associations with the risk factor and with the outcome are
often obtained from separate datasets, leading to a two-sample
IV analysis. However, due to the nature of major interna-
tional genetics consortia, often the datasets are not completely
disjoint, and some studies and participants are in common
between the two datasets. When there is some overlap, it is
unclear whether bias due to weak instruments would be in
the direction of the null (as in the case of zero overlap) or
in the direction of the observational association (as in the
case of complete overlap). While the sliding scale of bias
toward the observational association as the proportion of over-
lap increases has previously been demonstrated (Pierce &
Burgess, 2013), it is unclear in speciﬁc investigations whether
this bias should be of concern.
The aim of this paper is to investigate the direction
and degree of bias in a “two-sample” instrumental variable
analysis in which there is overlap between the two samples.
This is achieved by theoretical considerations and a series
of simulation studies with realistic parameters for Mendelian
randomization. The structure of the paper is as follows. First,
we explain why weak instrument bias occurs and the reason
for the direction of the bias (Section 2). Next, we present sim-
ulation studies and discuss their results (Section 3 for a con-
tinuous outcome, Section 4 for a binary outcome). We present
illustrations of the potential bias due to participant overlap in
example Mendelian randomization investigations using sum-
marized data from two large consortia (Section 5). Finally, we
discuss the wider relevance of these results, and in particular
the case of a two-sample investigation in which the genetic
variants were discovered in one of the datasets under analysis
(Section 6).
2 WEAK INSTRUMENT BIAS
We initially assume that the outcome is continuous and that
all regression analyses use a linear model. In the simplest case
with a single IV, the causal eﬀect of the risk factor on the out-
come can be estimated as a ratio of regression coeﬃcients
(Martens, Pestman, de Boer, Belitser, & Klungel, 2006). The
ratio estimate is the coeﬃcient from regression of the out-
come on the IV divided by the coeﬃcient from regression
of the risk factor on the IV (Didelez & Sheehan, 2007). In a
one-sample setting, weak instrument bias arises due to cor-
relation between the regression coeﬃcients in the numera-
tor and denominator as a result of confounding between the
risk factor and outcome (Nelson & Startz, 1990). In a two-
sample setting, the numerator and denominator in the ratio
method will be uncorrelated. Bias with a single IV is diﬃ-
cult to quantify, as the expected value of the ratio estimate is
undeﬁned, because of the small but ﬁnite probability that the
denominator in the ratio estimator (the IV–risk factor associ-
ation) is arbitrarily close to zero (Hahn, Hausman, & Kuer-
steiner, 2004). However, if the IV–risk factor association is
close to zero, then an IV analysis is unlikely to be performed
in practice, as the ﬁrst IV assumption (the only one that can
be tested directly) appears to be violated. In simulation stud-
ies, the median ratio estimate across simulations is usually
close to the true value of the causal eﬀect even with complete
sample overlap (a one-sample analysis) except in the case of
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extremely weak instruments (those for which the expected
strength of association with the risk factor corresponds to a
P-value above 0.05 Burgess & Thompson, 2011), indicating
that the practical consequences of bias with a single IV are
unlikely to be substantial (Angrist & Pischke, 2009).
2.1 Two-stage least squares method
When there are multiple IVs, the two-stage least squares
(2SLS) estimate can be obtained in a one-sample setting
with individual-level data by (i) regressing the risk factor on
the IVs (ﬁrst-stage regression), and then (ii) regressing the
outcome on ﬁtted values of the risk factor from the ﬁrst-
stage regression (second-stage regression). Weak instrument
bias can be explained as arising from overﬁtting in the ﬁrst-
stage regression model, which occurs at least in part due to
chance correlations of the IVs with confounders (Burgess &
Thompson, 2011). In a one-sample setting, the ﬁtted val-
ues from the ﬁrst-stage regression are therefore correlated
with the outcome in ﬁnite samples even in the absence of
a causal eﬀect. This leads to ﬁnite-sample bias of the 2SLS
estimate. The expected magnitude of this bias depends on
the strength of association between the IVs and the risk fac-
tor through the concentration parameter. The concentration
parameter (𝜇) is related to the expected value of the F statistic
from the regression of the risk factor on the IVs: for large sam-
ples, 𝔼(𝐹 ) = 𝜇
𝐾
+ 1, where 𝐾 is the number of IVs (Cragg &
Donald, 1993). We refer to the expected value of this F statis-
tic as the F parameter, to emphasize that this is a characteristic
of the population, and not simply a function of the observed
data.
In a two-sample setting with individual-level data, the
2SLS estimate can be calculated by obtaining estimates of
the ﬁrst-stage regression parameters in one dataset, and con-
structing ﬁtted values of the risk factor in the second dataset
using these estimates and the values of the IVs in the second
dataset (measurements of the risk factor in the second dataset
are not required). The outcome and the ﬁtted values of the
risk factor in the second-stage regression are no longer cor-
related due to confounding. This approach is also known as
split-sample 2SLS (Angrist & Krueger, 1995). The ﬁtted val-
ues of the risk factor are also equivalent (up to an additive
constant) to values of an externally weighted allele score (an
analysis approach used in Mendelian randomization (Burgess
& Thompson, 2013)) in the second dataset using the ﬁrst
sample to obtain the external weights. Any bias due to weak
instruments is in the direction of the null (Pierce & Burgess,
2013; Burgess et al., 2016b). This arises for the same reason
as regression dilution bias in observational studies (Frost &
Thompson, 2000). If the ﬁtted values of the risk factor are
imprecisely estimated (as will be the case with weak instru-
ments), then they will suﬀer from non-diﬀerential measure-
ment error, and bias in the second-stage regression will be in
the direction of the null.
2.2 Inverse-variance weighted method and
equivalence to 2SLS method
If individual-level data are not available, but instead summa-
rized data on the associations of the genetic variants with the
risk factor and with the outcome, then the 2SLS method can-
not be implemented. Instead, an inverse-variance weighted
(IVW) method is often employed that combines the ratio esti-
mates calculated separately for each IV, using a formula for
performing a ﬁxed-eﬀect meta-analysis (Burgess et al., 2013).
This method assumes that the IVs are uncorrelated (i.e., not
in linkage disequilibrium), although extensions for correlated
genetic variants have been proposed (Burgess et al., 2016b).
The estimate from the IVW method is equal to the estimate
from the 2SLS method asymptotically. The two estimates are
also equal in ﬁnite samples when the correlations between the
IVs are exactly zero (Burgess et al., 2016b). The level of weak
instrument bias in the IVW method has been shown to be the
same as that from the 2SLS method in realistic simulations
(Burgess et al., 2013). We therefore expect the results of this
paper to apply equally to analyses performed using the 2SLS
method and individual-level data, as to using the IVW method
and summarized data.
Although we use the 2SLS method in some simulation
studies of this paper for computational convenience, and we
refer to theoretical results for weak instrument bias derived
using the 2SLS method, the focus of this paper is the sum-
marized data setting. Results from the 2SLS method are pre-
sented because of their similarity with those from the IVW
method that can be performed using summarized data. If
individual-level data were available, then several alternative
approaches for mitigating weak instrument bias would be
possible, such as using either the limited information max-
imum likelihood (LIML) or the continuously updating esti-
mator (CUE) method (Davies et al., 2015), using a jack-
knife IV estimator (Angrist et al., 1999) (or equivalently
an allele score approach using leave-one-out cross-validated
weights Burgess & Thompson, 2013), or using an allele score
approach using equal or externally speciﬁed weights (Burgess
& Thompson, 2013). However, with summarized data, only
the ﬁnal option (equal or externally speciﬁed weights) is pos-
sible (Burgess et al., 2016b).
2.3 Magnitude of bias in a one-sample setting
The ordinary least squares (OLS, also known as standard least
squares regression) estimate is obtained by regressing the out-
come on the risk factor. This “observational” estimate is typi-
cally biased due to confounding. The relative bias of the 2SLS
estimate —the bias of the 2SLS estimate divided by the bias
of the OLS estimate—is approximately and asymptotically
equal to 1∕𝔼(𝐹 ) (Staiger & Stock, 1997), where 𝔼(𝐹 ) is the
“F parameter.” An F parameter of 10 therefore corresponds
to a 1∕10 = 10% relative bias of the 2SLS estimate compared
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to the OLS estimate. However, this calculation cannot be
directly employed for bias correction in an applied setting, as
the F statistic in a given dataset may diﬀer substantially from
the F parameter due to random variation (Burgess, Thomp-
son, & CRP CHD Genetics Collaboration, 2011). As weak
instrument bias occurs due to chance correlations with con-
founders, the reference OLS estimate should ideally be unad-
justed for measured confounders, unless these confounders
are also adjusted for in the IV estimate.
2.4 Expected bias of 2SLS estimator
The bias of the 2SLS estimator in a one-sample setting has
been considered theoretically (Nagar, 1959). One approxima-
tion to the bias is:
Bias of 2SLS estimator (one sample) =










where 𝜇 is the concentration parameter, 𝐾 is the number of
IVs, 𝜎2
𝑋
is the variance of the error in the ﬁrst-stage regres-
sion model, and 𝜎𝑋𝑌 is the covariance of the error terms in
the ﬁrst- and second-stage regression models (Bun & Wind-
meijer, 2011). In a two-sample setting, this formula may not
be directly applicable, as the sample sizes for the ﬁrst- and
second-stage regressions (and so the lengths of the error term
vectors) may diﬀer, in which case a covariance cannot be cal-
culated. If the sample sizes are equal, then we can decom-
pose the covariance into a term corresponding to individu-
als included in both regressions, and a term corresponding
to unrelated individuals that will have expectation zero. If
the sample sizes diﬀer, dependence between these two error
terms is still driven by individuals in common between these
two regressions, and the presence of individuals in only one
or other of the regressions will dilute this dependence. As
covariance is a linear operator in both its arguments, we
may therefore expect the bias of the 2SLS estimator to be




To investigate the degree and direction of bias in a “two-
sample” Mendelian randomization investigation where there
is overlap between the samples, we conduct a simulation
study. The data-generating model is given below.




𝛼𝑔𝑖𝑘 + 𝑢𝑖 + 𝜖𝑋𝑖
𝑦𝑖 = 𝛽𝑋𝑥𝑖 + 𝛽𝑈𝑢𝑖 + 𝜖𝑌 𝑖
𝑢𝑖 ∼ (0, 1), 𝜖𝑋𝑖 ∼ (0, 1), 𝜖𝑌 𝑖 ∼ (0, 1) independently
The 20 IVs (𝑔𝑖𝑘, 𝑘 = 1,… , 20) are indexed by 𝑘 and indi-
viduals are indexed by 𝑖. The IVs are modeled as indepen-
dently distributed biallelic single nucleotide polymorphisms
(SNPs) with a minor allele frequency of 0.3. The risk factor
(𝑥𝑖) is a linear function of the IVs, a confounder (𝑢𝑖), and an
independent error term (𝜖𝑋𝑖). The outcome (𝑦𝑖) is a linear
function of the risk factor, confounder, and another indepen-
dent error term (𝜖𝑌 𝑖). The IVs all have the same per allele
eﬀect on the risk factor (𝛼). The causal eﬀect of the risk fac-
tor on the outcome is 𝛽𝑋 , and the eﬀect of the confounder on
the outcome is 𝛽𝑈 .
We consider the cases of a positive causal eﬀect (𝛽𝑋 =
0.2) and a null causal eﬀect (𝛽𝑋 = 0), and take three
values of the confounder eﬀect on the outcome (𝛽𝑈 =
0.6, 1, 2). The IV strength is varied by taking three values of
𝛼 = 0.04, 0.06, 0.08. We consider cases where there is 0%
overlap, increasing in increments of 10% up to a 100% over-
lap. This is achieved by simulating data on 20, 000 individu-
als. Estimates were obtained using the 2SLS and IVW meth-
ods. The ﬁrst-stage regression is undertaken (or for the IVW
method, IV–risk factor associations are estimated) in the ﬁrst
10, 000 individuals, and the second-stage regression (IV–
outcome associations) in individuals 10, 001–20, 000 (0%
overlap), individuals 9,001–19, 000 (10% overlap), individu-
als 8,001–18, 000 (20% overlap), and so on. Hence all associ-
ations were estimated using 10, 000 individuals. Total 10, 000
simulations were considered for each set of parameters.
Although some aspects of the simulation study are not var-
ied here, we repeated the simulation study varying the num-
ber of IVs, and the total sample size (results not shown). In
each case, the amount of bias was almost identical between
scenarios in which the F parameter (expected value of the F
statistic) was similar. Hence, we would expect the results of
this simulation study to be generalizable to other situations,
and would view the F parameter (which depends on the sam-
ple size, number of IVs, and the proportion of variance in the
risk factor explained by the IVs) as the key measure of bias.
3.1 Results
Results are given in Table 1 and displayed visually in Figure 1.
For each set of parameters, the mean estimate from the 2SLS
method across simulations is given. Mean estimates from the
IVW method were equal to those from the 2SLS method to 3
decimal places, and median estimates across simulations from
both methods were similar to mean estimates. The Monte
Carlo standard error for the mean estimates is 0.002 or less in
all scenarios. Mean F and 𝑅2 (coeﬃcient of determination)
statistics from regression of the risk factor on the IVs based
on 10, 000 participants are provided to judge the strength of
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TABLE 1 Simulation 1 with continuous outcome and diﬀerent overlap proportions
Mean Mean Percentage 𝜷𝑿 = 𝟎.𝟐 𝜷𝑿 = 𝟎
𝜶 𝑭 𝑹𝟐 overlap 𝜷𝑼 = 𝟎.𝟔 𝜷𝑼 = 𝟏 𝜷𝑼 = 𝟐 𝜷𝑼 = 𝟎.𝟔 𝜷𝑼 = 𝟏 𝜷𝑼 = 𝟐
0.04 4.4 0.9% OLS 0.498 0.697 1.193 0.298 0.497 0.993
0% 0.156 0.157 0.161 −0.001 0.000 0.004
10% 0.167 0.173 0.186 0.006 0.012 0.024
20% 0.178 0.187 0.211 0.012 0.022 0.045
30% 0.189 0.203 0.237 0.019 0.033 0.067
40% 0.200 0.218 0.262 0.026 0.044 0.087
50% 0.211 0.233 0.287 0.033 0.055 0.108
60% 0.223 0.249 0.313 0.040 0.066 0.130
70% 0.234 0.264 0.339 0.047 0.077 0.152
80% 0.245 0.280 0.363 0.053 0.088 0.172
90% 0.256 0.294 0.389 0.060 0.098 0.194
100% 0.266 0.309 0.415 0.066 0.109 0.215
0.06 8.5 1.7% OLS 0.495 0.692 1.185 0.295 0.492 0.985
0% 0.178 0.179 0.176 0.000 0.000 −0.002
10% 0.184 0.186 0.189 0.003 0.005 0.009
20% 0.189 0.193 0.203 0.006 0.011 0.020
30% 0.194 0.201 0.215 0.009 0.016 0.031
40% 0.200 0.209 0.228 0.013 0.022 0.041
50% 0.206 0.216 0.242 0.016 0.027 0.052
60% 0.211 0.224 0.255 0.019 0.032 0.063
70% 0.216 0.231 0.268 0.023 0.038 0.074
80% 0.221 0.239 0.282 0.026 0.043 0.086
90% 0.226 0.246 0.295 0.028 0.048 0.097
100% 0.232 0.254 0.309 0.031 0.054 0.109
0.08 14.4 2.8% OLS 0.492 0.687 1.174 0.292 0.487 0.974
0% 0.187 0.187 0.187 0.000 0.000 0.000
10% 0.191 0.191 0.195 0.002 0.003 0.007
20% 0.194 0.195 0.203 0.004 0.006 0.014
30% 0.197 0.199 0.211 0.006 0.009 0.020
40% 0.200 0.204 0.218 0.008 0.011 0.026
50% 0.203 0.208 0.225 0.010 0.014 0.032
60% 0.206 0.213 0.232 0.012 0.018 0.038
70% 0.210 0.218 0.240 0.014 0.022 0.044
80% 0.213 0.222 0.248 0.016 0.024 0.050
90% 0.217 0.226 0.255 0.018 0.027 0.056
100% 0.220 0.230 0.264 0.020 0.030 0.064
Notes: Mean two-stage least squares (or equivalently, inverse-variance weighted) estimates with true causal eﬀect 𝛽𝑋 = 0.2 (positive eﬀect) and 𝛽𝑋 = 0 (null
eﬀect) for three values of genetic associations with the risk factor (𝛼), three values of the confounder eﬀect on the outcome (𝛽𝑈 ), and 11 values of the percentage
overlap between the two samples. The mean F statistic (𝐹 ), mean coeﬃcient of determination (𝑅2), and mean ordinary least squares (OLS) estimate are given
to judge the strength of the instrumental variables and the degree of confounding.
the instrumental variants. Ordinary least squares (OLS) esti-
mates are also provided to help judge the level and direction
of confounding.
With a positive causal eﬀect, the results demonstrate
clearly the transition from bias in the direction of the null with
no overlap, to bias in the direction of the confounded asso-
ciation with increasing overlap. This transition happens ear-
lier when the confounding is stronger, although the balance
point where the biases cancel out does not seem to depend
on the strength of the IVs: for 𝛽𝑈 = 0.6, it is around 40%; for
𝛽𝑈 = 1, it is around 28%; and 𝛽𝑈 = 2, it is around 16%. Fur-
ther simulations (not shown) suggest that the balance point
also depends on the magnitude of the causal eﬀect, so the
precise balance points in this simulation will not necessarily
6 BURGESS ET AL.






































F IGURE 1 Mean two-stage least squares/inverse-variance weighted estimates plotted against sample overlap for diﬀerent values of instrument strength
(𝛼 = 0.4, circle; 𝛼 = 0.6, triangle; 𝛼 = 0.8, plus) and diﬀerent values of the confounder eﬀect on the outcome (𝛽𝑈 = 0.6, black solid line; 𝛽𝑈 = 1, mid-gray
dashed line; 𝛽𝑈 = 2, light-gray dotted line). Left panel: positive causal eﬀect (𝛽𝑋 = 0.2); right panel: null causal eﬀect (𝛽𝑋 = 0)
hold in other cases. With a null causal eﬀect, there is no bias
with 0% overlap, and bias increases as the degree of overlap
increases.
3.2 Deriving analytic formulae for the expected bias
under the null and type 1 error rate
The relationship between the level of overlap and the mean
estimate appears to be linear throughout, both with a posi-
tive and with a null causal eﬀect. Equally, with a null causal
eﬀect, the bias is proportional to the eﬀect of the confounder
(𝛽𝑈 ), which in turn is proportional to the OLS estimate. This
suggests that a formula can be derived for the amount of bias
expected under the null hypothesis:
Bias under null = OLS estimate ×
Percentage overlap
100
× Relative bias (3)
where the relative bias is the reciprocal of the F parameter.
Given the bias and the standard error of an estimate, the
expected Type 1 (false positive) error rate for a two-sided test
of size 5% can be approximated analytically as:











whereΦ is the cumulative standard normal function. The vari-
ance of the IV estimate (the 2SLS or the IVW estimate) can
be approximated as:




where 𝑁 is the sample size for the IV–outcome association,
𝑅𝑌 is the residual outcome after subtracting the causal eﬀect
of the risk factor (𝑅𝑌 = 𝑌 − 𝛽𝑋𝑋), and 𝜌 is the correlation
between the IVs and the risk factor (the 𝑅2 statistic – the pro-
portion of variance in the risk factor explained by the IVs – is
an estimate of 𝜌2) (Nelson & Startz, 1990). The variance of
𝑅𝑌 is equal to the variance of 𝑌 when the causal eﬀect of the
risk factor on the outcome is zero. The relationship between
the F statistic and the 𝑅2 statistic (Dobson, 2001) is:





where 𝐾 is the number of IVs. For small values of 𝑅2, this
means that the F and 𝑅2 statistics are approximately linearly
related.
Hence, given the sample size, sample overlap percentage,
OLS estimate (in standard deviation units for the risk factor
and outcome, otherwise the standard deviations of risk factor
and outcome are required), and an estimate of the strength of
the IVs (either the F statistic or the 𝑅2 statistic), the bias and
Type 1 error rate can be calculated. R code for performing
these calculations is given in Web Appendix A1.
3.3 Validating the analytic formulae
To assess the validity of the analytic formulae for the bias
and Type 1 error rate, we conducted a further set of 10, 000
simulations in 10, 000 participants using model (2) under the
causal null (𝛽𝑋 = 0), with the strongest level of confounding
(𝛽𝑈 = 2) and 100% sample overlap, with a wider range of
values for the IV strength (𝛼 = 0.01, 0.02,… , 0.1, 0.15, 0.2)
to estimate the relative bias and empirical Type 1 error rate
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TABLE 2 Simulation 2 with continuous outcome to validate bias and type 1 error rate formulae
Mean Mean Relative Empirical Expected
𝜶 Mean 𝑭 Mean 𝑹𝟐 OLS estimate IV estimate bias (Mean 𝑭 )−𝟏 Type 1 error Type 1 error
0.01 1.2 0.2% 0.999 0.829 0.829 0.825 84.8% 89.5%
0.02 1.8 0.4% 0.998 0.531 0.532 0.545 65.5% 69.8%
0.03 2.9 0.6% 0.996 0.333 0.334 0.346 46.9% 46.1%
0.04 4.4 0.9% 0.993 0.216 0.218 0.229 32.5% 30.6%
0.05 6.3 1.2% 0.990 0.149 0.151 0.160 24.1% 21.8%
0.06 8.6 1.7% 0.985 0.109 0.111 0.117 19.2% 16.8%
0.07 11.3 2.2% 0.980 0.082 0.083 0.089 15.6% 13.6%
0.08 14.4 2.8% 0.974 0.062 0.064 0.069 12.4% 11.5%
0.09 18.0 3.5% 0.967 0.050 0.052 0.056 11.0% 10.1%
0.10 22.0 4.2% 0.960 0.040 0.042 0.046 9.8% 9.0%
0.15 48.3 8.8% 0.914 0.019 0.021 0.021 7.5% 6.6%
0.20 85.0 14.5% 0.856 0.010 0.012 0.012 5.9% 5.8%
Notes: Simulation results with null causal eﬀect 𝛽𝑋 = 0, and confounder eﬀect 𝛽𝑈 = 2 to estimate the relative bias and empirical Type 1 error rate (5% nominal
signiﬁcance level) of the two-stage least squares (or equivalently, inverse-variance weighted) instrumental variable (IV) estimate; the relative bias is the bias
of the IV estimate divided by the bias of the ordinary least squares (OLS) estimate. The relative bias is theoretically predicted to be close to the reciprocal of
the mean value of the F statistic, (Mean 𝐹 )−1.
(proportion of simulations for which the Wald test for the IV
estimate rejected the null) in each case.
These results are given in Table 2. The relative bias esti-
mates are close to 1∕𝔼(𝐹 ), as theoretically predicted (Staiger
& Stock, 1997). The expected Type 1 error rate was calculated
using the mean values of the 𝐹 statistic, 𝑅2 statistic, variance
of the risk factor and outcome, and the OLS estimate across
simulations. The empirical and expected Type 1 error rates
showed fairly close agreement, with the expected Type 1 error
rate tending to be a slight underestimate of the empirical rate
for all but the weakest of instruments. The Monte Carlo stan-
dard error for the empirical Type 1 error rate was around 0.2%.
Additional simulations are provided in Web Appendix A2.
We varied the number of IVs (𝐾 = 10) and considered diﬀer-
ent overlap proportions from 0% to 100% (Web Table A1).
In this case, closer correspondence was observed between
the expected and observed Type 1 error rates throughout,
although these were across a narrower range. We also varied
the sample size (𝑁 = 1, 000, Web Table A2), and considered
the case of a binary risk factor (Web Table A3). In both these
cases, there was close agreement between the expected and
observed values of the relative bias and the Type 1 error rate.
There was some deviation in Type 1 error estimates with a
smaller sample size, with Type 1 error rates underestimated
with stronger instruments (F parameter 5–10). However, this
discrepancy appeared to be due to problems of maintaining
nominal Type 1 error rates withweak instrumentsmore gener-
ally rather than mis-estimation of the relative bias, and would
be resolved by using methods for inference that do not rely
on the IV estimate having a normal distribution (for exam-
ple, Fieller’s theorem (Burgess, Small, & Thompson, 2015)
or inversion of the Anderson–Rubin test statistic Mikusheva,
2010).
3.4 The F parameter and the F statistic
The bias of an IV estimate depends on the expected value
of the F statistic (referred to here as the F parameter). How-
ever, in practice, the F parameter will be unknown and only
the measured F statistic (an estimate of the F parameter) will
be available in a single dataset. The F statistic can be highly
variable. For example, we previously took a large study and
divided it into 16 equally sized substudies at random (Burgess
et al., 2011). By construction, each of these substudies should
have had the same expected F statistic. However, the mea-
sured F statistics ranged from 3.4 to 22.6 (mean was 10.8).
One practical suggestion is to use an estimate of the
F statistic based on an external dataset to ensure that the esti-
mate of bias is not dependent on the F statistic in the data
under analysis. This can be achieved by taking the value of
𝑅2 (which is independent of sample size) from the exter-
nal dataset and calculating the corresponding F statistic for
the sample size under investigation; the 𝑅2 for a single SNP
is 2 ?̂?2 ×𝑀𝐴𝐹 × (1 −𝑀𝐴𝐹 ), where the genetic association
with the risk factor ?̂? is in standard deviation units, and𝑀𝐴𝐹
is the minor allele frequency. Additionally, the bias calcula-
tion can be repeated taking a lower value of the F statistic
to address the problem that the F statistic in the data under
analysis may be an overly optimistic estimate of the F param-
eter. For example, one could take the lower limit from a conﬁ-
dence interval for the F parameter (such as the lower limit of a
one-sided 95% conﬁdence interval—only the lower tail of the
interval is relevant). A method for constructing a conﬁdence
interval for the non-centrality parameter of an F distribution
(from which a conﬁdence interval for the F parameter can be
obtained) has been considered previously (Venables, 1975);
this method is outlined in Web Appendix A3, and code for
implementing the method is provided.
8 BURGESS ET AL.
4 SIMULATION STUDY—BINARY
OUTCOME
With a binary outcome in a case-control setting (as is com-
mon for Mendelian randomization with a disease outcome),
the ratio estimate is calculated by dividing the IV–outcome
coeﬃcient from logistic regression by the IV–risk factor coef-
ﬁcient from linear regression (Didelez, Meng, & Sheehan,
2010b). A two-sample method can also be performed by
replacing the linear model in the second-stage regression of
the outcome on the ﬁtted values of the risk factor with a
logistic model. When summarized data are available, a causal
eﬀect estimate can be obtained based using the IVW method
to combine the ratio estimates, as in the case of a continu-
ous outcome. There are some technical issues relating to the
interpretation of these estimates with a binary outcome and a
logistic regression model due to the non-collapsibility of odds
ratios (they approximate a population-averaged log odds ratio
per unit change in the distribution of the risk factor Burgess
& CHD CRP Genetics Collaboration, 2013), but each is a
consistent estimator under the null, and each provides a valid
test of the null hypothesis of no causal eﬀect (Vansteelandt,
Bowden, Babanezhad, & Goetghebeur, 2011).
In principle, similar analytical formulae for bias under the
null and Type 1 error rate could be developed with a binary
outcome (𝑌 = 0, 1). This would require a diﬀerent formula for
the variance of the IV estimate, as this depends on the num-
ber and ratio of participants with outcome events (Burgess,
2014):
Variance of IV estimate (binary)
≃ 1
𝑁 var(𝑋) 𝜌2 ℙ(𝑌 = 1)ℙ(𝑌 = 0)
. (7)
However, if the data on the outcome are derived from a
case-control sample, then typically the associations with the
risk factor are estimated in control participants only (Bow-
den & Vansteelandt, 2011). This is for three main reasons: to
avoid reverse causation, particularly if the risk factor is mea-
sured after the outcome event in cases; to avoid biases due to
outcome-dependent sampling (associations may be present in
the case-control sample even if they are absent in the under-
lying population) (Didelez, Kreiner, & Keiding, 2010); and
because the controls are a more representative sample of the
population as a whole (Didelez & Sheehan, 2007). Hence,
even if there is overlap between datasets with a binary out-
come, then provided that the IV–risk factor associations are
estimated in the controls only, bias may not be substantial.
To investigate this, we simulated data using a similar data-
generating mechanism as previously:





𝛼𝑔𝑖𝑘 + 𝑢𝑖 + 𝜖𝑋𝑖
logit(𝜋𝑖) = −3 + 𝛽𝑋𝑥𝑖 + 𝛽𝑈𝑢𝑖
𝑦𝑖 ∼ Binomial(1, 𝜋𝑖)
𝑢𝑖 ∼ (0, 1), 𝜖𝑋𝑖 ∼ (0, 1) independently
A logistic-linear relationship is assumed between the proba-
bility of an outcome event (𝜋𝑖) and the risk factor and con-
founder. A case-control sample was generated by simulat-
ing data on 100, 000 individuals, and taking the ﬁrst 5,000
with an event (𝑦𝑖 = 1) as cases, and the ﬁrst 5,000 without
an event (𝑦𝑖 = 0) as controls. IV–outcome associations were
estimated in all participants using logistic regression. The IV–
risk factor associations were estimated both on the controls
only, and in all participants (controls and cases). This was a
one-sample analysis (100% sample overlap). We set 𝛽𝑋 = 0
(null causal eﬀect) and 𝛽𝑈 = 1, and considered scenarios with
𝛼 = 0.01, 0.02, 0.03, 0.04, 0.05, 0.08.
4.1 Results
The mean estimates and empirical Type 1 (false positive)
error rates based on 10, 000 simulated datasets are given in
Table 3. With IV–risk factor associations estimated in the
controls only, there was no detectable bias in the IV esti-
mates even with extremely weak instruments, nor was there
any inﬂation of Type 1 error rates. This suggests that a con-
ventional Mendelian randomization analysis with a binary
outcome in which the associations of the IV with the risk
factor are only estimated in control participants provides a
natural robustness against weak instrument bias, even in a
one-sample setting. With IV–risk factor associations esti-
mated in all participants, bias was similar to that with a con-
tinuous outcome, with relative bias close to 1∕𝔼(𝐹 ) on the
log odds ratio scale and empirical Type 1 error rates close to
the predicted values. However, the approximations were less
accurate compared with the continuous outcome case, partic-
ularly for the weakest of instruments. This suggests that the
same analytic formulae can be used with a binary outcome as
with a continuous outcome, except with a diﬀerent expression
for the standard error of the IV estimate. R code for perform-
ing these calculations is given in Web Appendix A1.
5 EXAMPLES: SAMPLE OVERLAP
BETWEEN LARGE CONSORTIA
We consider several Mendelian randomization analyses that
could be undertaken using published summarized data from
large consortia, and discuss the potential for bias due to par-
ticipant overlap in each case.
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TABLE 3 Simulation 3 with binary outcome to validate bias and type 1 error rate formulae
Mean observational Mean IV Relative Empirical Expected
𝜶 Mean 𝑭 Mean 𝑹𝟐 estimate estimate bias (Mean 𝑭 )−𝟏 Type 1 Type 1
Risk factor measurements taken in controls only
0.01 1.1 0.4% 0.481 0.001 0.002 - 4.9% -
0.02 1.4 0.6% 0.481 0.000 0.000 - 5.2% -
0.03 2.0 0.8% 0.479 −0.003 0.007 - 4.8% -
0.04 2.7 1.1% 0.478 −0.001 −0.001 - 5.0% -
0.05 3.7 1.5% 0.476 0.000 0.000 - 5.2% -
0.08 7.9 3.1% 0.469 0.000 0.001 - 4.7% -
Risk factor measurements taken in all participants
0.01 1.2 0.3% 0.481 0.360 0.748 0.837 24.4% 29.1%
0.02 1.8 0.4% 0.481 0.237 0.493 0.561 17.4% 21.1%
0.03 2.8 0.5% 0.479 0.149 0.311 0.363 12.8% 15.2%
0.04 4.1 0.8% 0.478 0.099 0.207 0.242 10.0% 11.7%
0.05 5.9 1.2% 0.476 0.068 0.142 0.170 8.4% 9.6%
0.08 13.6 2.6% 0.469 0.030 0.064 0.074 6.3% 6.9%
Notes: Mean instrumental variable (IV) estimates and empirical Type 1 error rate (5% nominal signiﬁcance level) from inverse-variance weighted method
with binary outcome for null causal eﬀect (𝛽𝑋 = 0) and six values of genetic associations with the risk factor (𝛼) in a case-control setting, with the risk factor
measurements taken in control participants only and with the risk factor measurements taken in all participants. Observational estimates are log odds ratios from
logistic regression of the outcome on the risk factor, and IV estimates are log odds ratios calculated using logistic regression for the IV–outcome association
and linear regression for the IV–risk factor association.
1. Body mass index and lipid traits: We consider an analy-
sis to estimate the causal eﬀect of body mass index (BMI)
on various lipid traits using data from the GIANT (Gen-
etic Investigation of Anthropometric Traits) consortium
(Locke et al., 2015) and the GLGC (Global Lipids Genet-
ics Consortium) (The Global Lipids Genetics Consortium,
2013). 55 common studies are mentioned in the papers
authored by these two consortia, comprising around 71%
of participants in the GLGC. The 97 genetic variants
reported as associated with BMI at a genome-wide level of
signiﬁcance explain around 2.7% of the variance in BMI in
the GIANT dataset (sample size = 339 224), correspond-
ing to an F statistic of approximately 0.0271−0.027 ×
339 126
97 =
97.0. The lower limit of a one-sided 95% conﬁdence inter-
val for the F parameter is 93.7 (see Web Appendix A3
for calculation). Hence, despite the substantial overlap
between the two consortia, considerable weak instrument
bias would not be expected.
2. Body mass index and coronary heart disease risk:
Although the F statistic suggests that weak instrument
bias would not be substantial in any case, we consider
the binary outcome of coronary heart disease (CHD), and
investigate the degree of overlap between participants in
the GIANT consortium above and the CARDIoGRAM-
plusC4D consortium (The CARDIoGRAMplusC4D Con-
sortium, 2013). Of the 38 studies that appear in CAR-
DIoGRAMplusC4D, 27 appear in GIANT in some form.
In many cases, both case and control participants are
included in GIANT. Hence, even though CHD is a binary
outcome, the sample overlap between the two consortia
could lead to weak instrument bias if the F parameter for
BMI were lower.
3. Educational attainment: A genetic score for an indi-
vidual’s number of years of schooling (“EduYears”)
constructed using ﬁve genetic variants associated with
EduYears at a genome-wide level of signiﬁcance (𝑃 < 5 ×
10−8) explained about 0.1% of the variance in EduYears
in the discovery sample of 101, 069 individuals (corre-
sponding F statistic = 20.2) (Rietveld et al., 2013). Asso-
ciations were also reported for a follow-up sample of
25, 490 individuals (corresponding F statistic = 5.1). The
corresponding lower limits of the one-sided 95% conﬁ-
dence intervals for the F parameter are 14.0 and 2.3 (see
Web Appendix A3). Hence, a Mendelian randomization
investigation using associations from the discovery sample
should not lead to substantial weak instrument bias, but an
investigation using associations from the follow-up sam-
ple may be severely aﬀected by weak instruments. How-
ever, if associations from the discovery sample are used
in a Mendelian randomization investigation, then bias (in
particular, selection bias) may be more serious due to win-
ner’s curse; this issues is explored further in the discussion.
These examples suggest that sample overlap between major
international consortia may be substantial. Bias from weak
instruments in very large consortia may not be substantial,
but in moderately large consortia, potential bias, and inﬂated
Type 1 error rates should be investigated.
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6 DISCUSSION
In this paper, we have shown that bias in a Mendelian ran-
domization investigation with a continuous outcome in a two-
sample setting is linearly related to the proportion of sample
overlap between the two datasets. We have provided and val-
idated analytical formulae for the expected bias and Type 1
error rate under the null given the F parameter (the expected
value of the F statistic), the observational (OLS) estimate,
the sample size, and the sample overlap percentage. With a
binary outcome, provided that the IV–risk factor associations
are estimated in the control participants only, bias due to sam-
ple overlap is negligible and Type 1 error rates are at nominal
levels. If IV–risk factor associations are estimated in all par-
ticipants, then bias is similar with a binary outcome (on the
log odds ratio scale) as with a continuous outcome. Formulae
for estimating the bias and Type 1 error rate under the null are
given, and R code for calculating these quantities is given in
Web Appendix A1. This code is implemented in a web appli-
cation at https://sb452.shinyapps.io/overlap.
6.1 Overlap with datasets of diﬀerent size
If the datasets are of diﬀerent size, then the percentage over-
lap in these formulae should be taken with respect to the larger
dataset, as this determines the correlation between the associ-
ation estimates. This is because only individuals in both stud-
ies will lead to correlation between the association estimates,
and additional individuals in either the association with the
risk factor or with the outcome will attenuate any correlation.
For example, if the smaller dataset has 1,000 participants, and
the larger dataset has 10, 000 participants, then the sample
overlap is only 10% even if all of the participants from the
smaller dataset are included in the larger dataset.
6.2 Additional bias from genetic discovery
Weak instrument bias will be accentuated if the genetic vari-
ants were initially discovered in the data under analysis. This
is due to winner’s curse; if several genetic variants in truth
have similar magnitudes of association with the risk factor,
the association of the one that is the strongest in the data
under analysis is likely to be overestimated (Burgess et al.,
2011; Taylor et al., 2014). As this overestimation will gen-
erally mean that the associations with confounders are by
chance stronger than expected, bias will occur if the discovery
dataset is used in the estimation of the IV–risk factor or the
IV–outcome associations. In a binary outcome setting, pro-
vided that only control participants were used in the discovery
dataset, this should not lead to bias. However, if controls and
cases were both used in the discovery dataset, this will lead
to weak instrument bias.
There is no clear way to evaluate the bias due to overlap
between the discovery sample and the dataset(s) used in a
Mendelian randomization investigation. Hence, in such cases
caution should be expressed, particularly if a genetic variant
is close to the threshold statistical signiﬁcance level for dis-
covery or for inclusion in the Mendelian randomization analy-
sis. In particular, data-driven approaches for choosing genetic
variants to be included in a Mendelian randomization analysis
should be avoided. Analytical approaches to correct genetic
associations for winner’s curse may be useful in such a situa-
tion (Bowden & Dudbridge, 2009).
6.3 Increased bias in MR-egger method
The recently introduced MR-Egger method method has
advantages over the conventional two-stage least squares and
inverse-variance weighted methods in terms of some robust-
ness to the instrumental variable assumptions being vio-
lated (Bowden, Davey Smith, & Burgess, 2015). Although
weak instrument bias using data from large consortia may
be low for conventional methods, bias for the MR-Egger
method has been shown to be considerably more pronounced,
both attenuation in a two-sample setting and bias toward the
observational association in a one-sample setting (Bowden,
Davey Smith, Haycock, & Burgess, 2016a; Burgess, Bow-
den, Dudbridge, & Thompson, 2016a). This means that bias
due to sample overlap may be more serious for the MR-Egger
method. In a two-sample setting, bias in the MR-Egger esti-
mate does not depend on the proportion of variance explained
by the IVs, but rather on the variability between the IV associ-
ations with the risk factor. Hence, for the MR-Egger method,
an I2 heterogeneity statistic is a better indicator of bias than
the F statistic (Bowden et al., 2016). Further research is
needed to derive an analytical formula for weak instrument
bias in the MR-Egger method in the one-sample setting.
6.4 Practical recommendations
If there is sample overlap that is likely to lead to substan-
tial bias and inﬂated Type 1 error rates in a “two-sample”
Mendelian randomization investigation, several approaches
are available. If possible, the genetic associations with the risk
factor could be derived from another non-overlapping data
source (possibly a subset of the original studies). A disadvan-
tage of this is the potential loss of eﬃciency if the genetic
associations are estimated less precisely (Burgess & Thomp-
son, 2013). Alternatively, equal weights can be used, although
again, there is a potential loss of power to detect a causal eﬀect
(Burgess et al., 2016b). (Software code for performing a sum-
marized data analysis equivalent to a equally weighted allele
score analysis is provided in Web Appendix A4.) Finally, sen-
sitivity analyses can be performed using fewer but stronger
genetic variants (and hence increasing the F parameter).
For consortia that publish genetic association estimates
with continuous risk factors, we recommend that such esti-
mates do not include case participants from case-control
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studies. This will help reduce sample overlap in future
Mendelian randomization studies that investigate the causal
eﬀect of the continuous risk factor on disease risk.
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